Harmen Beurmanjer

109 References fatalities related to non-medical use. Neuroscience and Biobehavioral Reviews . https://doi.org/10.1016/j. neubiorev.2015.03.012 Craig, K., Gomez, H. F., McManus, J. L., & Bania, T. C. (2000). Severe gamma-hydroxybutyrate withdrawal: A case report and literature review. Journal of EmergencyMedicine , 18 (1), 65–70. https://doi.org/10.1016/S0736-4679( 99)00163-8 Crunelli, V., Emri, Z., & Leresche, N. (2006). Unravelling the brain targets of γ-hydroxybutyric acid. Current Opinion in Pharmacology , Vol. 6, pp. 44–52. https://doi.org/10.1016/j.coph.2005.10.001 Cruz, H. G., Ivanova, T., Lunn, M. L., Stoffel, M., Slesinger, P. A., & Lüscher, C. (2004). Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system. Nature Neuroscience , 7 (2), 153–159. https://doi. org/10.1038/nn1181 Cryan, J. F., & Kaupmann, K. (2005). Don’t worry “B” happy!: A role for GABA B receptors in anxiety and depression. Trends in Pharmacological Sciences , Vol. 26, pp. 36–43. https://doi.org/10.1016/j.tips.2004.11.004 Cumming, T. B., Lowe, D., Linden, T., & Bernhardt, J. (2018). The AVERT MoCA Data: Scoring Reliability in a Large Multicenter Trial. Assessment . https://doi.org/10.1177/1073191118771516 Czapla, M., Simon, J. J., Richter, B., Kluge, M., Friederich, H. C., Herpertz, S., …Loeber, S. (2016). The impact of cognitive impairment and impulsivity on relapse of alcohol-dependent patients: implications for psychotherapeutic treatment. Addiction Biology , 21 (4), 873–884. https://doi.org/10.1111/adb.12229 De Jong, C. A. J., Kamal, R., Dijkstra, B. A. G., & De Haan, H. A. (2011). Gamma-hydroxybutyrate detoxification by titration and tapering. European Addiction Research , 18 (1), 40–45. https://doi.org/10.1159/000333022 de Weert-van Oene, G. H., Schellekens, A. F. A., Dijkstra, B. A. G., Kamal, R., & de Jong, C. A. J. (2013). Detoxification of patients with GHB dependence. Tijdschrift Voor Psychiatrie , 55 (11), 885–890. Degenhardt, L. (2003). GHB: An overview . Adicciones , 15 (SUPPL. 2), 167–177. Degenhardt, Louisa, Darke, S., & Dillon, P. (2002). GHB use among Australians: Characteristics, use patterns and associated harm. Drug and Alcohol Dependence , 67 (1), 89–94. https://doi.org/10.1016/S0376-8716( 02)00017-0 Degenhardt, Louisa, Darke, S., & Dillon, P. (2003). The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction , 98 (2), 199–204. https://doi.org/10.1046/j.1360-0443.2003.00265.x Delic, M. (2019). Inpatient management of GHB/GBL withdrawal. Psychiatria Danubina . Diclemente, C. C., Corno, C. M., Graydon, M. M., Wiprovnick, A. E., & Knoblach, D. J. (2017). Motivational interviewing, enhancement, and brief interventions over the last decade: A review of reviews of efficacy and effectiveness. Psychology of Addictive Behaviors . https://doi.org/10.1037/adb0000318 Dijkstra, B. A. G., Kamal, R., van Noorden, M. S., de Haan, H., Loonen, A. J. M., & De Jong, C. A. J. (2017). Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project. Drug and Alcohol Dependence , 170 , 164–173. https://doi.org/10.1016/j.drugalcdep.2016.11.014 Dines, A. M., Wood, D. M., Yates, C., Heyerdahl, F., Hovda, K. E., Giraudon, I., …Dargan, P. I. (2015). Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clinical Toxicology , 53 (9), 893–900. https://doi.org/10.3109/15563650.2015.1088157 Dyer, J. E., Roth, B., & Hyma, B. A. (2001). Gamma-hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine , 37 (2), 147–153. https://doi.org/10.1067/mem.2001.112985 European Monitoring Centre for Drugs and Drug Addiction. (2016). European Drug Report 2016: Trends and Developments. In European Monitoring of Drugs and Drugs Addiction . https://doi.org/10.2810/88175 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2018). European Monitoring Centre for Drugs and Drug Addiction: European Drug Report 2018: Trends and Developments. In EMCDDA, Lisbon, June 2018 . https://doi.org/10.2810/800331 F., R. P. (2017). Effects of gamma hydroxybutyrate (GHB) induced coma on long-term memory and brain function. European Neuropsychopharmacology , 27 , S1067. https://doi.org/10.1080/10550490175053211 Fattore, L., Cossu, G., Martellotta, M. C., Deiana, S., & Fratta, W. (2001). Baclofen antagonises intravenous self-adminis- tration of gamma-hydroxybutyric acid in mice. Neuroreport , 12 (10), 2243–2246. Ferraro, L., Tanganelli, S., O’Connor, W. T., Francesconi, W., Loche, A., Gessa, G. L., & Antonelli, T. (2001). γ-Hydroxybu- tyrate modulation of glutamate levels in the hippocampus: An in vivo and in vitro study. Journal of Neurochemistry , 78 (5), 929–939. https://doi.org/10.1046/j.1471-4159.2001.00530.x From the Centers for Disease Control. Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate. (1991). JAMA: The Journal of the AmericanMedical Association , 265 (4), 447–448. https://doi.org/10.1001/ jama.265.4.447